Nghiên cứu giá trị tiên lượng tử vong của NT-proBNP ở bệnh nhân hội chứng mạch vành cấp
Tóm tắt
Nghiên cứu giá trị tiên lượng tử vong của NT-proBNP ở bệnh nhân hội chứng mạch vành cấpTài liệu tham khảo
1. Steg PG, James SK, Atar d, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj/ehs215.
2. Hamm CW, bassand JP, Agewall S, et al. ESC guidelines for the management of acute coro- nary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the
management of acute coronary syndromes in patients presenting without persistent ST-segment eleva- tion of the European Society of Cardiology. Eur Heart J doi:10.1093/eurheartj/ehr236.
3. O’Gara PT, Kushner FG, Ascheim dd, et al. 2013 ACCF/AHA guideline for the manage- ment of ST-elevation myocardial infarction. A report of the American College of Cardiology Founda- tion/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2013;61:e78-140.
4. Amsterdam EA, Wenger NK, brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes. A report of the American College of Cardiol- ogy/American Heart Association Task Force on practice guidelines. Circulation 2014;130:e344-426.
5. Heeschen C, Hamm CW, Mitrovic v, et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-3212.
6. Jernberg T, Stridsberg M, venge P, Lindahl b. N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-445.
7. bjorklund E, Jernberg T, Johanson P, et al. Admission N-terminal probrain natriuretic pep- tide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Heart 2006;92:735-740.
8. Morrow dA, Antman EM, Charlesworth A, et al. TiMi risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardial early ii trial substudy. Circulation 2000;102:2031-2037.
9. braunwald E, Cannon CP. Unstable angina and non ST-segment elevation myocardial infarc- tion. Braunwald’s heart disease, 13th edition, 2011:p.1178.
10. James SK, Lindahl b, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-iV. Circulation 2003;108:275-281.
11. Galvani M, Ottani F, Oltrona L, et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004;110:128-134.
12. bazzino O, Fuselli J, bottoc F, et al. Relative value of N-terminal probrain natriuretic peptide, TiMi risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST- elevation acute coronary syndromes. Eur Heart J 2004;25:859-866.
